Pilar de la Puente, Ph.D. and Kareem Azab, Ph.D., Washington University School of Medicine (image)

Washington University School of Medicine

Caption

Pilar de la Puente, Ph.D. (left), and Kareem Azab, Ph.D., of Washington University School of Medicine in St. Louis, have developed a screening tool that may predict quickly and more accurately the best treatments for individual patients with multiple myeloma. The 3-D tissue-engineered bone marrow (3DTEBM) cultures pictured were developed with bone marrow samples to help determine which treatments are most effective.

Credit

Robert Boston

Usage Restrictions

None

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.